Sumitomo Mitsui Financial Group Inc. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 12.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 24,323 shares of the healthcare conglomerate’s stock after purchasing an additional 2,743 shares during the quarter. Sumitomo Mitsui Financial Group Inc.’s holdings in UnitedHealth Group were worth $9,504,000 as of its most recent filing with the SEC.
Several other large investors have also added to or reduced their stakes in UNH. OLD Mission Capital LLC bought a new position in UnitedHealth Group during the third quarter valued at about $439,000. Camden National Bank boosted its stake in UnitedHealth Group by 5.5% during the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after buying an additional 100 shares in the last quarter. Centaurus Financial Inc. boosted its stake in UnitedHealth Group by 2.1% during the second quarter. Centaurus Financial Inc. now owns 1,542 shares of the healthcare conglomerate’s stock valued at $618,000 after buying an additional 32 shares in the last quarter. Van ECK Associates Corp boosted its stake in UnitedHealth Group by 15.6% during the second quarter. Van ECK Associates Corp now owns 91,304 shares of the healthcare conglomerate’s stock valued at $36,562,000 after buying an additional 12,294 shares in the last quarter. Finally, Capital Advisors Ltd. LLC boosted its stake in UnitedHealth Group by 2,155.2% during the second quarter. Capital Advisors Ltd. LLC now owns 654 shares of the healthcare conglomerate’s stock valued at $262,000 after buying an additional 625 shares in the last quarter. 86.20% of the stock is owned by institutional investors.
Several brokerages have recently commented on UNH. Credit Suisse Group upped their target price on UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a report on Friday, October 15th. Morgan Stanley upped their target price on UnitedHealth Group from $499.00 to $526.00 and gave the company an “overweight” rating in a report on Wednesday, December 1st. SVB Leerink began coverage on UnitedHealth Group in a report on Monday, September 27th. They set an “outperform” rating and a $480.00 target price for the company. Truist Securities upped their target price on UnitedHealth Group from $520.00 to $575.00 and gave the company a “buy” rating in a report on Wednesday, January 5th. Finally, UBS Group upped their target price on UnitedHealth Group from $435.00 to $452.00 and gave the company a “neutral” rating in a report on Wednesday, December 1st. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $500.54.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion for the quarter, compared to analyst estimates of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.51 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th were issued a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date of this dividend was Friday, December 3rd. UnitedHealth Group’s dividend payout ratio is 35.98%.
In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the firm’s stock in a transaction that occurred on Monday, October 25th. The stock was sold at an average price of $448.72, for a total value of $33,654,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total value of $1,111,750.00. The disclosure for this sale can be found here. Corporate insiders own 0.55% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.